Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | FABP3 | P05413 | 9/20 | 0.52 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11668421 | 1.00 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Adipic Acid SCHEMBL1194226 | 0.96 | CA1 (0.58) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Octanedioate SCHEMBL8386996 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Sebacic Acid SCHEMBL6562957 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Azelaic Acid SCHEMBL11428758 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Azelaic Acid SCHEMBL3975767 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL11046980 | 0.93 | CA1 (0.63) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Sebacic Acid SCHEMBL3936260 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Sebacic Acid SCHEMBL847655 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL20577558 | 0.93 | CA1 (0.63) | CA1FABP3FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10738068-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | Centre National de la Recherche Scientifique—CNRS (FR) | 2020-08-11 | — | — | US | disclosed |
| US-20180346500-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-12-06 | — | — | US | disclosed |
| US-10065979-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2018-09-04 | — | — | US | disclosed |
| US-20110052650-A1 | POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST | Centre National De La Recherche Scientifique - CNR S (FR) | 2011-03-03 | — | — | US | disclosed |
| US-20100226991-A1 | SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS- (FR) | 2010-09-09 | — | — | US | disclosed |
| US-20100209354-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2010-08-19 | — | — | US | disclosed |
| US-4225661-A | DIAZO RESIN LAYER, PHOTOCHROMIC DYE AND ADDITION POLYMER OVERLAYER | THE RICHARDSON COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052650-A1 | POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST | MITF, SLCO2B1, SLCO2A1 | CA1 90/4885FABP3 424/4885FFAR3 883/4885 |
| US-20100226991-A1 | SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE | SLCO2A1, SLCO4C1, SLCO2B1 | CA1 898/4885FABP3 1234/4885FFAR3 3353/4885 |
| US-10065979-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | SLC39A3, SLC40A1, AOC3 | CA1 657/4885FABP3 110/4885FFAR3 594/4885 |
| US-20180346500-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | SLC39A3, SLC40A1, AOC3 | CA1 644/4885FABP3 110/4885FFAR3 587/4885 |
| US-10738068-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | SLC40A1, FECH, FTH1 | CA1 441/4885FABP3 418/4885FFAR3 1805/4885 |
| US-20100209354-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | SLC39A3, SLC40A1, AOC3 | CA1 657/4885FABP3 110/4885FFAR3 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.